11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1

Robert J. Weil, Alexander Vortmeyer, Steve Huang, Roland Boni, Irina A. Lubensky, Svetlana Pack, Stephen J. Marx, Zhengping Zhuang, Edward H. Oldfield

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Pituitary adenomas may develop sporadically or as part of the multiple endocrine neoplasia type 1 (MEN 1) syndrome. The gene responsible for MEN I syndrome was recently identified and cloned. Low rates of MEN I gene mutations and deletions have been reported in sporadic pituitary adenomas. To elucidate the role of the MEN 1 gene in the pathogenesis of MEN 1-associated pituitary tumors, we examined pituitary adenomas from 11 MEN 1 patients for the presence of 11q13 allelic loss. Ten of the 11 pituitary tumors were informative by PCR-based loss of heterozygosity analysis. Using a combination of family pedigree analysis and restriction analysis directed at the mutated allele in 8 of the 10 informative cases, it was demonstrated in all 8 cases that it is the wild-type allele that undergoes deletion. All 11 tumors, 4 of which were growth hormone secreting, were additionally analyzed for mutation in the Gs α subunit (gsp) gene. None of the tumors (0 of 11 tumors) revealed a gsp gene mutation. Therefore, genetic alterations of the MEN I gene seem to play a dominant role in MEN 1-associated pituitary tumorigenesis, whereas gsp gene mutations do not seem to be a frequent event in either growth hormone- secreting or other types of MEN 1-associated pituitary tumors. These results suggest that MEN 1-associated pituitary tumors develop via genetic pathways that differ from those of most sporadic pituitary tumors.

Original languageEnglish (US)
Pages (from-to)1673-1678
Number of pages6
JournalClinical Cancer Research
Volume4
Issue number7
StatePublished - Jul 1 1998
Externally publishedYes

Fingerprint

Multiple Endocrine Neoplasia
Multiple Endocrine Neoplasia Type 1
Loss of Heterozygosity
Pituitary Neoplasms
Genes
Mutation
Growth Hormone
Alleles
Neoplasms
Gene Deletion
Pedigree
Carcinogenesis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Weil, R. J., Vortmeyer, A., Huang, S., Boni, R., Lubensky, I. A., Pack, S., ... Oldfield, E. H. (1998). 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1. Clinical Cancer Research, 4(7), 1673-1678.

11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1. / Weil, Robert J.; Vortmeyer, Alexander; Huang, Steve; Boni, Roland; Lubensky, Irina A.; Pack, Svetlana; Marx, Stephen J.; Zhuang, Zhengping; Oldfield, Edward H.

In: Clinical Cancer Research, Vol. 4, No. 7, 01.07.1998, p. 1673-1678.

Research output: Contribution to journalArticle

Weil, RJ, Vortmeyer, A, Huang, S, Boni, R, Lubensky, IA, Pack, S, Marx, SJ, Zhuang, Z & Oldfield, EH 1998, '11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1', Clinical Cancer Research, vol. 4, no. 7, pp. 1673-1678.
Weil, Robert J. ; Vortmeyer, Alexander ; Huang, Steve ; Boni, Roland ; Lubensky, Irina A. ; Pack, Svetlana ; Marx, Stephen J. ; Zhuang, Zhengping ; Oldfield, Edward H. / 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1. In: Clinical Cancer Research. 1998 ; Vol. 4, No. 7. pp. 1673-1678.
@article{d58320adce9d41dd83b271ce8a9c136b,
title = "11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1",
abstract = "Pituitary adenomas may develop sporadically or as part of the multiple endocrine neoplasia type 1 (MEN 1) syndrome. The gene responsible for MEN I syndrome was recently identified and cloned. Low rates of MEN I gene mutations and deletions have been reported in sporadic pituitary adenomas. To elucidate the role of the MEN 1 gene in the pathogenesis of MEN 1-associated pituitary tumors, we examined pituitary adenomas from 11 MEN 1 patients for the presence of 11q13 allelic loss. Ten of the 11 pituitary tumors were informative by PCR-based loss of heterozygosity analysis. Using a combination of family pedigree analysis and restriction analysis directed at the mutated allele in 8 of the 10 informative cases, it was demonstrated in all 8 cases that it is the wild-type allele that undergoes deletion. All 11 tumors, 4 of which were growth hormone secreting, were additionally analyzed for mutation in the Gs α subunit (gsp) gene. None of the tumors (0 of 11 tumors) revealed a gsp gene mutation. Therefore, genetic alterations of the MEN I gene seem to play a dominant role in MEN 1-associated pituitary tumorigenesis, whereas gsp gene mutations do not seem to be a frequent event in either growth hormone- secreting or other types of MEN 1-associated pituitary tumors. These results suggest that MEN 1-associated pituitary tumors develop via genetic pathways that differ from those of most sporadic pituitary tumors.",
author = "Weil, {Robert J.} and Alexander Vortmeyer and Steve Huang and Roland Boni and Lubensky, {Irina A.} and Svetlana Pack and Marx, {Stephen J.} and Zhengping Zhuang and Oldfield, {Edward H.}",
year = "1998",
month = "7",
day = "1",
language = "English (US)",
volume = "4",
pages = "1673--1678",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1

AU - Weil, Robert J.

AU - Vortmeyer, Alexander

AU - Huang, Steve

AU - Boni, Roland

AU - Lubensky, Irina A.

AU - Pack, Svetlana

AU - Marx, Stephen J.

AU - Zhuang, Zhengping

AU - Oldfield, Edward H.

PY - 1998/7/1

Y1 - 1998/7/1

N2 - Pituitary adenomas may develop sporadically or as part of the multiple endocrine neoplasia type 1 (MEN 1) syndrome. The gene responsible for MEN I syndrome was recently identified and cloned. Low rates of MEN I gene mutations and deletions have been reported in sporadic pituitary adenomas. To elucidate the role of the MEN 1 gene in the pathogenesis of MEN 1-associated pituitary tumors, we examined pituitary adenomas from 11 MEN 1 patients for the presence of 11q13 allelic loss. Ten of the 11 pituitary tumors were informative by PCR-based loss of heterozygosity analysis. Using a combination of family pedigree analysis and restriction analysis directed at the mutated allele in 8 of the 10 informative cases, it was demonstrated in all 8 cases that it is the wild-type allele that undergoes deletion. All 11 tumors, 4 of which were growth hormone secreting, were additionally analyzed for mutation in the Gs α subunit (gsp) gene. None of the tumors (0 of 11 tumors) revealed a gsp gene mutation. Therefore, genetic alterations of the MEN I gene seem to play a dominant role in MEN 1-associated pituitary tumorigenesis, whereas gsp gene mutations do not seem to be a frequent event in either growth hormone- secreting or other types of MEN 1-associated pituitary tumors. These results suggest that MEN 1-associated pituitary tumors develop via genetic pathways that differ from those of most sporadic pituitary tumors.

AB - Pituitary adenomas may develop sporadically or as part of the multiple endocrine neoplasia type 1 (MEN 1) syndrome. The gene responsible for MEN I syndrome was recently identified and cloned. Low rates of MEN I gene mutations and deletions have been reported in sporadic pituitary adenomas. To elucidate the role of the MEN 1 gene in the pathogenesis of MEN 1-associated pituitary tumors, we examined pituitary adenomas from 11 MEN 1 patients for the presence of 11q13 allelic loss. Ten of the 11 pituitary tumors were informative by PCR-based loss of heterozygosity analysis. Using a combination of family pedigree analysis and restriction analysis directed at the mutated allele in 8 of the 10 informative cases, it was demonstrated in all 8 cases that it is the wild-type allele that undergoes deletion. All 11 tumors, 4 of which were growth hormone secreting, were additionally analyzed for mutation in the Gs α subunit (gsp) gene. None of the tumors (0 of 11 tumors) revealed a gsp gene mutation. Therefore, genetic alterations of the MEN I gene seem to play a dominant role in MEN 1-associated pituitary tumorigenesis, whereas gsp gene mutations do not seem to be a frequent event in either growth hormone- secreting or other types of MEN 1-associated pituitary tumors. These results suggest that MEN 1-associated pituitary tumors develop via genetic pathways that differ from those of most sporadic pituitary tumors.

UR - http://www.scopus.com/inward/record.url?scp=0031745736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031745736&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 1673

EP - 1678

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 7

ER -